These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9703938)

  • 1. Formation of a novel topotecan metabolite in the hormone-independent human prostate carcinoma cell lines DU-145 and PC-3.
    Platzer P; Herzog W; Thalhammer T; Hamilton G; Haberl I; Jäger W
    Anticancer Res; 1998; 18(4A):2737-41. PubMed ID: 9703938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotransformation of topotecan in the isolated perfused rat liver: identification of three novel metabolites.
    Platzer P; Schaden S; Thalhammer T; Hamilton G; Rosenberg B; Silgoner I; Jäger W
    Anticancer Res; 1998; 18(4A):2695-700. PubMed ID: 9703931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro].
    Zhang H; Lü JJ; Gao QZ; Zhang J
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):382-5. PubMed ID: 16638347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumour prodrug development using cytochrome P450 (CYP) mediated activation.
    Patterson LH; McKeown SR; Robson T; Gallagher R; Raleigh SM; Orr S
    Anticancer Drug Des; 1999 Dec; 14(6):473-86. PubMed ID: 10834269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation.
    Alimirah F; Chen J; Basrawala Z; Xin H; Choubey D
    FEBS Lett; 2006 Apr; 580(9):2294-300. PubMed ID: 16580667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis.
    Griffith TS; Kemp TJ
    Cancer Chemother Pharmacol; 2003 Sep; 52(3):175-84. PubMed ID: 12811515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRP1 not MDR1 gene expression is the predominant mechanism of acquired multidrug resistance in two prostate carcinoma cell lines.
    Zalcberg J; Hu XF; Slater A; Parisot J; El-Osta S; Kantharidis P; Chou ST; Parkin JD
    Prostate Cancer Prostatic Dis; 2000 Aug; 3(2):66-75. PubMed ID: 12497102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
    Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145.
    Trzeciak AR; Nyaga SG; Jaruga P; Lohani A; Dizdaroglu M; Evans MK
    Carcinogenesis; 2004 Aug; 25(8):1359-70. PubMed ID: 15044326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling of angiogenic cytokines produced by hormone- and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol.
    Karaca B; Kucukzeybek Y; Gorumlu G; Erten C; Gul MK; Cengiz E; Atmaca H; Uzunoglu S; Sanli UA; Karabulut B; Uslu R
    Eur Cytokine Netw; 2008 Dec; 19(4):176-84. PubMed ID: 19103523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone in androgen-dependent and -independent prostate cancer cell lines.
    Copeland RL; Das JR; Bakare O; Enwerem NM; Berhe S; Hillaire K; White D; Beyene D; Kassim OO; Kanaan YM
    Anticancer Res; 2007; 27(3B):1537-46. PubMed ID: 17595773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenomedullin prevents apoptosis in prostate cancer cells.
    Abasolo I; Montuenga LM; Calvo A
    Regul Pept; 2006 Jan; 133(1-3):115-22. PubMed ID: 16297990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.
    Eiseman JL; Rogers FA; Guo Y; Kauffman J; Sentz DL; Klinger MF; Callery PS; Kyprianou N
    Cancer Res; 1998 Nov; 58(21):4864-70. PubMed ID: 9809992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated eosinophils upregulate the metastasis suppressor molecule E-cadherin on prostate tumor cells.
    Furbert-Harris PM; Parish-Gause D; Hunter KA; Vaughn TR; Howland C; Okomo-Awich J; Forrest K; Laniyan I; Abdelnaby A; Oredipe OA
    Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1009-16. PubMed ID: 14682382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
    Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
    Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topotecan-induced alterations in the amount and stability of human DNA topoisomerase I in solid tumor cell lines.
    Devy J; Wargnier R; Pluot M; Nabiev I; Sukhanova A
    Anticancer Res; 2004; 24(3a):1745-51. PubMed ID: 15274350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
    Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
    Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.
    Herness EA; Naz RK
    Cancer Res; 2003 Jan; 63(2):329-36. PubMed ID: 12543784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.